With a U.S. green light for its encapsulated cell therapy technology in the bag, privately held biotech Neurotech ...

Atrandi’s Semi-Permeable Capsule (SPC) technology is transforming high-throughput single-cell research. These aqueous compartments, enclosed by a semi-permeable shell, isolate cells and nucleic ...

Phase 3 trials demonstrated ENCELTO significantly slowed macular photoreceptor loss in MacTel patients over 24 months.

and he observed that these bacteria had the smooth capsules characteristic of the S strain. Based on these observations, Griffith hypothesized that a chemical component from the virulent S cells ...

Atrandi Biosciences' Semi-Permeable Capsule (SPC) technology in action: SPCs selectively retain cells and nucleic acids while allowing small molecules to flow through. Atrandi Biosciences' Semi ...

This investment will accelerate the company's expansion into the U.S. market, support the growth of its semi-permeable capsule (SPC) technology, and advance new product development to enable ...